Biotech componentsMolecule

Products 1 to 10 of 38

Biotech components: Molecule
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (4 years ago)
Date last modified: 2020/12/18 14:40 (4 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Medical
Market status: Under Development
Organization type(s): Private Company
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Bio-based Polybutylene Succinate by GC Innovation America + Myriant
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: Japan + China + Korea + USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/09 16:26 (6 years ago)
Known funding amount: 110,000,000 USD
Funding types: Government + Venture Capital
Industry: Industrial
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Input
Cadnano by Autodesk
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/01/30 12:03 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Science
Market status: On the market
Organization type(s): Public Company
Product categories: Design
Production process: Closed Production
Source: SynBio Database
Trading symbol: ADSK (NASDAQ)
Value chain stage: Platform
Cell-cultured Seafood (#1) by Finless Foods
Biotech components: Animal + Molecule
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2018/11/19 09:36 (6 years ago)
Date last modified: 2018/11/19 09:37 (6 years ago)
Known funding amount: 3,500,000 USD
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Food
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
CRISPR-Cas9 by CRISPR
Biotech components: Molecule
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: Research
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 13:59 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Science
Market status: On the market
Organization type(s): Public Company
Product categories: Research
Production process: Closed Production
Source: Web search
Trading symbol: CRSP (NASDAQ)
Value chain stage: Finished Product
CropOS by Benson Hill Biosystems
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA + Spain + Brazil
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/06/21 16:07 (5 years ago)
Known funding amount: 34,700,000 USD
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Research
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
crPhage by Locus Biosciences
Biotech components: Gene Editing + Molecule + Virus
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:10 (5 years ago)
Date last modified: 2019/09/12 15:10 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Health + Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment + Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Molecule
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Canada + Switzerland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/05/15 15:47 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Open Release
Source: Web search
Trading symbol: BAS (ETR)
Value chain stage: Input
digitalDNA by Applied DNA Sciences
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/01/30 12:02 (6 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Security
Market status: On the market
Organization type(s): Public Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Platform